PROM1 and glioma: By evaluating CD133 expression by immunohistochemistry in a series of 95 gliomas of various grade and histology, authors reported an inverse correlation between the proportion of CD133+ cells, and their topological organization in clusters, and progression-free survival (PFS) and OS (Zeppernick et al., 2008).